First Disease Modifying Treatment for Endometriosis

FimmCyte AG

Incorporated

06.01.2022

Headquarters

Basel

Support

One in 10 women suffer from Endometriosis: a painful, chronic, infertility causing and recurrent disease. Endometriosis has a physical health burden comparable to cancer, yet only one new treatment was approved for it in the past decade. An unacceptable state given the inadequacy of current treatments which are only palliative, with countless side effects. Endometriosis' burden reverberates through the healthcare system, economy, and society with millions of women suffering and billions of direct and indirect costs. To address this unmet medical need, we engineered a first-in-class treatment that has shown efficacy in eliminating endometriosis tissue in the lab and animal models which we aim to bring to the clinic in the next few years and give women back control of their body.